To Save Payors Time, Effort and Resources, MEDai and Gold Standard Collaborate on New CMS Medication Therapy Management ...( ORLANDO Fla. July 9 /- MEDai Inc. a...),Health

ORLANDO, Fla., July 9 /PRNewswire/ -- MEDai, Inc. and Gold Standard, Inc., two Elsevier companies, today introduced MTM 360, a complete medication therapy management (MTM) system that enables health plans, benefit sponsors and other payors to successfully meet CMS's expanded MTM Program requirements for 2010 and beyond for their Medicare Part D business - from enrollment guidelines, medication reviews and interventions, to reporting and outcomes measurement. MTM 360 combines the power of MEDai's Risk Navigator Guidelines(TM) and Gold Standard's MTM Exchange.

MEDai's Risk Navigator Guidelines incorporates more than 140 best practice guidelines developed by organizations like NCQA, AHRQ, PQA and others. This robust solution offers numerous advantages for Part D benefit sponsors, including the ability to:

• modify or create guidelines to identify members for MTM program participation
• manage enrollment of targeted beneficiaries per CMS requirements
• monitor the medication compliance and gaps in therapy for members
• deliver relevant information to the point of care

"The MEDai solution supports health plans as they work to enhance care quality and safety and control avoidable medical expenses," said Swati Abbott, president of MEDai. "Risk Navigator Guidelines allows health plans to identify, stratify and monitor a patient population in real-time. Using this solution will be indispensable in improving outcomes in health and the business of health."

Gold Standard's contribution to MTM 360 is MTM Exchange, which supplies customizable documentation and reporting of MTM services, as well as patient and provider communication. Users can:

• perform comprehensive and targeted medication review
  '/>"/>